Correlation Between AN2 Therapeutics and INmune Bio

Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AN2 Therapeutics and INmune Bio, you can compare the effects of market volatilities on AN2 Therapeutics and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and INmune Bio.

Diversification Opportunities for AN2 Therapeutics and INmune Bio

-0.21

Correlation Coefficient

AN2 Therapeutics  INmune Bio

Very good diversification

The 3 months correlation between AN2 and INmune is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and INmune Bio go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and INmune Bio

Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the INmune Bio. In addition to that, AN2 Therapeutics is 1.44 times more volatile than INmune Bio. It trades about -0.01 of its total potential returns per unit of risk. INmune Bio is currently generating about 0.01 per unit of volatility. If you would invest  765.00  in INmune Bio on September 4, 2024 and sell it today you would lose (225.00) from holding INmune Bio or give up 29.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

AN2 Therapeutics  vs.  INmune Bio

AN2 Therapeutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

INmune Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's primary indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with AN2 Therapeutics and INmune Bio

The main advantage of trading using opposite AN2 Therapeutics and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.

The idea behind AN2 Therapeutics and INmune Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.